Workflow
Geovis Insighter Technology(920116)
icon
Search documents
星图测控(920116) - 中信建投证券股份有限公司关于中科星图测控技术股份有限公司关联交易的核查意见
2025-11-17 10:32
中信建投证券股份有限公司(以下简称"中信建投证券"或"保荐机构")作为 中科星图测控技术股份有限公司(以下简称"星图测控""公司"或"发行人")向不 特定合格投资者公开发行股票并在北京证券交易所上市的保荐机构,根据《证券 发行上市保荐业务管理办法》《北京证券交易所上市公司持续监管办法(试行)》 《北京证券交易所股票上市规则》《北京证券交易所证券发行上市保荐业务管理 细则》等有关规定,对星图测控本次关联交易事项进行了核查,核查情况及核查 意见如下: 一、关联交易概述 因项目需要,公司计划针对通信卫星姿轨控和供电分系统设计项目以邀请招 标方式确定供应商。2025 年 11 月 5 日,基于公平、公正、诚实信用的原则,经 过招标评标工作,公司拟确定中科卫星(山东)信息技术有限公司(以下简称"中 科卫星信息")为中标单位,中标金额为 1,140.37 万元。中科卫星科技集团有限 公司为公司董事及公司控股股东董事担任董事的单位,中科卫星信息为中科卫星 科技集团有限公司的全资子公司。公司基于实质重于形式的原则,将中科卫星信 息认定为公司关联方。 二、关联方基本情况 (一)关联方概述及关联关系 中信建投证券股份有限公司 关 ...
星图测控(920116) - 关联交易公告
2025-11-17 10:31
证券代码:920116 证券简称:星图测控 公告编号:2025-117 中科星图测控技术股份有限公司 关联交易公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、关联交易概述 (一)关联交易概述 因项目需要,公司计划针对通信卫星姿轨控和供电分系统设计项目以邀请招 标方式确定供应商。2025 年 11 月 5 日,基于公平、公正、诚实信用的原则,经 过招标评标工作,公司拟确定中科卫星(山东)信息技术有限公司(以下简称"中 科卫星信息")为中标单位,中标金额为 1,140.37 万元。中科卫星科技集团有限 公司为公司董事及公司控股股东董事担任董事的单位,中科卫星信息为中科卫星 科技集团有限公司的全资子公司。公司基于实质重于形式的原则,将中科卫星信 息认定为公司关联方。 (二)决策与审议程序 2025 年 11 月 17 日,公司召开第一届董事会第三十次会议审议通过了《关 于关联交易的议案》,表决结果:同意 8 票;反对 0 票;弃权 0 票。关联董事回 避表决。上述议案已经公司第一届独立董事专门会议第 ...
星图测控(920116) - 第一届董事会第三十次会议决议公告
2025-11-17 10:30
第一届董事会第三十次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 (一)会议召开情况 1.会议召开时间:2025 年 11 月 17 日 2.会议召开地点:公司会议室 3.会议召开方式:现场结合通讯方式 证券代码:920116 证券简称:星图测控 公告编号:2025-116 中科星图测控技术股份有限公司 二、议案审议情况 (一)审议通过《关于关联交易的议案》 1.议案内容: 因项目需要,公司计划针对通信卫星姿轨控和供电分系统设计项目以邀请招 4.发出董事会会议通知的时间和方式:2025 年 11 月 11 日以邮件方式发出 5.会议主持人:董事长胡煜 6.会议列席人员:部分高级管理人员 7.召开情况合法合规的说明: 本次会议召集、召开、议案审议程序等方面符合《公司法》和《公司章程》 的有关规定。 (二)会议出席情况 会议应出席董事 9 人,出席和授权出席董事 9 人。 标方式确定供应商。2025 年 11 月 5 日,基于公平、公正、诚实信用的原则,经 过招标评标 ...
星图测控(920116):太空服务管理提供商,测管仿算全产业链构筑核心壁垒
Shanxi Securities· 2025-11-17 07:58
Investment Rating - The report assigns a "Buy-B" rating for the company, indicating a positive outlook for its stock performance in the near term [3][9]. Core Insights - The company has demonstrated strong revenue growth, achieving a revenue of 188 million yuan in the first three quarters of 2025, representing a year-on-year increase of 15.57%. The net profit attributable to the parent company reached 63 million yuan, up 25.28% year-on-year [4]. - The rapid development of China's commercial space industry presents significant market opportunities for space management services, with a notable increase in satellite launches both globally and domestically [4][5]. - The company is positioned as a leading provider of space management services, focusing on satellite tracking, measurement, and control, which are essential for the growing complexity of satellite constellations [5][6]. Financial Performance - The company forecasts a net profit of 127 million yuan for 2025, with a compound annual growth rate (CAGR) of 49.0% from 2025 to 2027. The earnings per share (EPS) are projected to be 0.79 yuan in 2025, increasing to 1.27 yuan by 2027 [9][12]. - The revenue is expected to grow from 352 million yuan in 2025 to 762 million yuan in 2027, reflecting a robust growth trajectory [12][13]. - The company maintains a gross margin above 50% and a net margin around 30%, indicating strong profitability [7][12]. Market Position and Strategy - The company is leveraging its proprietary "Observer" platform to integrate AI technologies into its space management services, enhancing operational efficiency and service offerings [6][8]. - The company plans to launch its own sensing satellite constellation to improve space situational awareness and provide comprehensive support for satellite collision avoidance and operational control [8]. - The revenue mix is balanced between special and commercial sectors, with a focus on expanding its client base and enhancing service capabilities in both areas [7][9].
晨会纪要:对近期重要经济金融新闻、行业事件、公司公告等进行点评-20251110
Xiangcai Securities· 2025-11-10 03:22
Macro Strategy - In October, China's exports showed a year-on-year decline of -1.10%, marking the first negative growth since March 2025, which affected the cumulative year-on-year growth rate, decreasing from 6.10% in September to 5.30% in October. This decline is attributed to a high base in October 2024 and a temporary escalation in trade conflicts between China and the US in early October 2025 [3][4]. Market Overview - From November 3 to November 7, 2025, A-share indices experienced wide fluctuations, with the Shanghai Composite Index rising by 1.08% and the ChiNext Index increasing by 0.65%. The market is expected to continue a "slow bull" trend with wide fluctuations in November due to reduced short-term trade conflict risks between China and the US [4][5]. - Among the 31 first-level industries, the top performers were electric equipment and coal, with weekly increases of 4.98% and 4.52%, respectively. Conversely, the beauty care and computer sectors saw declines of -3.10% and -2.54% [6][7]. North Exchange Market - As of November 7, 2025, the North Exchange had 282 listed stocks, with an average total market value of 908.24 billion yuan, reflecting a 1.24% increase from the previous week. The liquidity decreased, with average trading volume dropping by 17.23% [11][12]. - The highest weekly gain was recorded by Danna Biological, which surged by 377.78% in its first week of trading, while the largest decline was seen in Beiyikang, which fell by 12.35% [13]. Vaccine Industry - The vaccine industry is experiencing structural differentiation, with companies like Kangtai Biological and Zhonghui Biological making significant advancements in vaccine development for specific populations, such as infants and pregnant women. The updated technical guidelines emphasize the importance of vaccination for high-risk groups [17][21]. - The vaccine sector's performance remains under pressure, with a year-to-date decline of -1.57%. The industry is focusing on innovation and international expansion to navigate current challenges [19][21]. - The vaccine sector's price-to-earnings ratio (PE) is currently at 99.07X, reflecting a decrease of 4.97X from the previous week, while the price-to-book ratio (PB) remains stable at 1.94X [20]. Investment Recommendations - The vaccine industry is advised to focus on innovation and international markets, as the current market conditions present challenges due to supply-demand imbalances and intense competition. Companies with strong technological capabilities and differentiated product lines are recommended for investment [21][23].
北交所今年“最牛新股”,突传利好!
Core Viewpoint - The company, Xingtian Measurement and Control, is set to launch its rocket measurement and control business, which is expected to significantly boost its revenue due to the increasing demand for rocket control services as China's space launch activities grow rapidly [1][3]. Group 1: Business Development - The company has initiated capability verification for core payloads, including onboard processors, which will be tested on two experimental satellites next year [1][2]. - Xingtian Measurement and Control has developed specialized software for rocket measurement and control management, currently in the final stages of integration and testing [1][3]. - The company has provided measurement and control services for over 300 satellites, with steady growth in business scale [2]. Group 2: Market Opportunities - The demand for space situational awareness data services is strong, with anticipated revenue from single satellite data services at a considerable level [2]. - Future revenue models are expected to include government-to-government data transactions, services for satellite owners to mitigate collision risks, and data services for third-party institutions like insurance companies [2]. Group 3: Strategic Positioning - The company is leveraging its technical expertise in space measurement and control, supported by capital market resources, to enhance its market competitiveness [3]. - Xingtian Measurement and Control is aligned with national policies and the strategic goal of becoming a space power, positioning itself to meet significant national strategic needs [3]. - The company aims to increase R&D investment in key areas such as space situational awareness, space traffic management, and on-orbit services, focusing on providing autonomous, secure, and efficient space management services [3].
星图测控(920116) - 董事换届公告
2025-11-06 11:01
证券代码:920116 证券简称:星图测控 公告编号:2025-107 中科星图测控技术股份有限公司董事换届公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导 性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、董事换届的基本情况 根据《公司法》及公司章程的有关规定,公司董事会于 2025 年 11 月 6 日审议并通 过: 提名胡煜先生为公司董事,任职期限三年,本次换届尚需提交股东会审议,自股东 会决议通过之日起生效。该人员持有公司股份 0 股,占公司股本的 0%,不是失信联合 惩戒对象。 提名牛威先生为公司董事,任职期限三年,本次换届尚需提交股东会审议,自股东 会决议通过之日起生效。该人员持有公司股份 0 股,占公司股本的 0%,不是失信联合 惩戒对象。 提名姚琳女士为公司董事,任职期限三年,本次换届尚需提交股东会审议,自股东 会决议通过之日起生效。该人员持有公司股份 0 股,占公司股本的 0%,不是失信联合 惩戒对象。 提名李会丹女士为公司董事,任职期限三年,本次换届尚需提交股东会审议,自股 东会决议通过之日起生效。该人员持有公司股份 0 股, ...
星图测控(920116) - 投资者关系活动记录表
2025-11-06 11:01
中科星图测控技术股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间:2025 年 11 月 5 日 活动地点:公司会议室、价值在线(www.ir-online.cn)网络互动 证券代码:920116 证券简称:星图测控 公告编号:2025-115 回复: 公司融合人工智能大模型与航天垂直领域专业模型,构建分钟级响应的智能 计算平台,实现卫星任务规划、轨道预警、故障诊断等关键环节的智能决策与自 动执行,全面提升卫星运行效率与太空管理智能化水平,推动航天信息系统向自 主可控、高效协同的智能化方向发展。同时,人工智能大模型的应用能够进一步 扩大公司技术优势,提升公司业务承接能力,降低人员成本,提高利润率。后续, 公司智能计算平台产品发布后,相信能够带来更加直观的感受。 问题 2:公司对太空感知星座盈利模式及预期的判断 ...
星图测控(920116) - 独立董事提名人声明与承诺(赵素艳)
2025-11-06 11:01
一、被提名人已同时符合以下条件: (一)具备上市公司运作的基本知识,熟悉相关法律法规、部门规章、规范 性文件及北交所业务规则; 证券代码:920116 证券简称:星图测控 公告编号:2025-110 中科星图测控技术股份有限公司 独立董事提名人声明与承诺 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 提名人中科星图测控技术股份有限公司董事会,现提名赵素艳为中科星图测 控技术股份有限公司第二届董事会独立董事候选人,并已充分了解被提名人职业、 学历、职称、详细的工作经历、全部兼职、有无重大失信等不良记录等情况。被 提名人已书面同意出任中科星图测控技术股份有限公司第二届董事会独立董事 候选人(参见该独立董事候选人声明与承诺)。提名人认为,被提名人具备独立 董事任职资格,与中科星图测控技术股份有限公司之间不存在任何影响其独立性 的关系,且提名人与被提名人不存在利害关系或者可能妨碍被提名人独立履职的 其他关系,具体声明并承诺如下: (二)具有五年以上履行独立董事职责所必需的法律、会计或者经济等工作 经验; (三 ...
星图测控(920116) - 独立董事提名人声明与承诺(谢传梅)
2025-11-06 11:01
一、被提名人已同时符合以下条件: (一)具备上市公司运作的基本知识,熟悉相关法律法规、部门规章、规范 性文件及北交所业务规则; 证券代码:920116 证券简称:星图测控 公告编号:2025-109 中科星图测控技术股份有限公司 独立董事提名人声明与承诺 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 提名人中科星图测控技术股份有限公司董事会,现提名谢传梅为中科星图测 控技术股份有限公司第二届董事会独立董事候选人,并已充分了解被提名人职业、 学历、职称、详细的工作经历、全部兼职、有无重大失信等不良记录等情况。被 提名人已书面同意出任中科星图测控技术股份有限公司第二届董事会独立董事 候选人(参见该独立董事候选人声明与承诺)。提名人认为,被提名人具备独立 董事任职资格,与中科星图测控技术股份有限公司之间不存在任何影响其独立性 的关系,且提名人与被提名人不存在利害关系或者可能妨碍被提名人独立履职的 其他关系,具体声明并承诺如下: (二)具有五年以上履行独立董事职责所必需的法律、会计或者经济等工作 经验; (三 ...